Nanobiotix (NBTX) Other Non-Current Liabilities (2019 - 2025)

Nanobiotix (NBTX) has 7 years of Other Non-Current Liabilities data on file, last reported at $590170.1 in Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 27.84% year-over-year to $590170.1; the TTM figure through Dec 2025 stood at $590170.1 (up 27.84% YoY), while the FY2025 annual figure was $572814.3, up 22.51% from the prior year.
• Other Non-Current Liabilities improved to $590170.1 in Q4 2025, from $461633.2 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $590170.1 in Q4 2025 and bottomed at $275466.8 in Q4 2022.
• A 5-year average of $407716.3 and a median of $363782.8 in 2021 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2021 — Other Non-Current Liabilities declined 26.3% — and 2024, when it jumped 32.83%.
• Year by year, Other Non-Current Liabilities stood at $363782.8 in 2021, then fell by 24.28% to $275466.8 in 2022, then climbed by 26.16% to $347528.6 in 2023, then jumped by 32.83% to $461633.2 in 2024, then grew by 27.84% to $590170.1 in 2025.
• The last three Other Non-Current Liabilities figures came in at $590170.1 (Q4 2025), $461633.2 (Q4 2024), and $347528.6 (Q4 2023), per Business Quant data.

Peer Comparison